Predict your next investment

Venture Capital
allegisnlcapital.com

See what CB Insights has to offer

Investments

12

Portfolio Exits

1

About AllegisNL

AllegisNL is an early-stage venture capital firm that invests in globally disruptive companies at the intersection of technology and finance.

AllegisNL Headquarter Location

200 Page Mill Rd Suite 100

Palo Alto, California, 94306,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest AllegisNL News

Lumiata Raises Series B Funding Co-Led by Defy.vc and AllegisNL Capital

Jan 18, 2021

Share Lumiata Sees Rapid Growth in Demand and Adoption of AI Applications for Healthcare Amid the COVID-19 Volatility and Risk AI for Healthcare company, Lumiata announced that it had completed $14 million in Series B funding. The round was co-led by venture capital firms Defy.vc and AllegisNL Capital along with existing investors Khosla Ventures and Blue Venture Fund. Lumiata is modernizing how risk and care are managed in healthcare. The friction-free predictive applications and machine learning tools enable healthcare companies to build and expand their AI capabilities. Lumiata will use the funding to scale its enterprise-grade AI platform and invest in customer acquisition and success. The company plans to open a new office in Guadalajara, Mexico in 2021. “Lumiata is breaking new grounds in the adoption of AI across healthcare’s core functions. We relaunched Lumiata two years ago with a mission to democratize AI to reduce the cost of care and improve outcomes. We have an even greater purpose to realize this mission as COVID-19 changed healthcare and our world forever,” said Lumiata CEO Dilawar Syed. “We will accelerate our investment in product, customers, and people to grow and scale the business.” “Lumiata excels at building trusted relationships with its customers,” said Dalbir Bains, FGC Health’s chairman, president and CEO, a Lumiata customer. “They have delivered results that help us manage consumer risks for co-morbidities. Our long partnership means that we can depend on them long-term to help us manage our pharmacy business.” Lumiata’s suite of products includes predictive applications for healthcare business teams to manage underwriting and clinical costs and risks for improved decision support, transparency, and patient centricity. Lumiata’s machine learning toolkit is purpose-built for healthcare data scientists to build and deploy predictive models with speed and ease. Lumiata’s automated data management, pre-built models, and AutoML capabilities provide a low-code option for healthcare organizations with limited data science expertise.

AllegisNL Investments

12 Investments

AllegisNL has made 12 investments. Their latest investment was in Eve Financial as part of their Seed VC - II on June 6, 2021.

CBI Logo

AllegisNL Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/30/2021

Seed VC - II

Eve Financial

$2M

No

1

5/10/2021

Series C

Kin Insurance

$63.9M

No

1

3/24/2021

Seed VC

Eve Financial

$1.44M

Yes

Undisclosed Investors

1

1/14/2021

Series D

Subscribe to see more

$99M

Subscribe to see more

10

11/4/2020

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/30/2021

5/10/2021

3/24/2021

1/14/2021

11/4/2020

Round

Seed VC - II

Series C

Seed VC

Series D

Series B - II

Company

Eve Financial

Kin Insurance

Eve Financial

Subscribe to see more

Subscribe to see more

Amount

$2M

$63.9M

$1.44M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Undisclosed Investors

Sources

1

1

1

10

10

AllegisNL Portfolio Exits

1 Portfolio Exit

AllegisNL has 1 portfolio exit. Their latest portfolio exit was Kin Insurance on May 19, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/19/2021

Acq - Pending

1

Date

5/19/2021

Exit

Acq - Pending

Companies

Valuation

Acquirer

Sources

1

AllegisNL Team

2 Team Members

AllegisNL has 2 team members, including current Managing Director, Spencer Tall.

Name

Work History

Title

Status

Spencer Tall

APV Technology Partners, Asia Pacific Ventures, and Marubun

Managing Director

Current

Victor Westerlind

GE Ventures, RockPort Capital Partners, InterWest Partners, Applied Materials, Candescent Technologies, and Stanford University

Managing Director

Current

Name

Spencer Tall

Victor Westerlind

Work History

APV Technology Partners, Asia Pacific Ventures, and Marubun

GE Ventures, RockPort Capital Partners, InterWest Partners, Applied Materials, Candescent Technologies, and Stanford University

Title

Managing Director

Managing Director

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.